agilon health (NYSE:AGL) Trading Up 6.4% – Time to Buy?

Shares of agilon health, inc. (NYSE:AGL) shot up 6.4% during mid-day trading on Friday . The company traded as high as $2.35 and last traded at $2.33. 281,456 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 2,576,343 shares. The stock had previously closed at $2.19.

Analysts Set New Price Targets

Several equities analysts have commented on AGL shares. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Macquarie started coverage on shares of agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, agilon health currently has a consensus rating of “Hold” and an average target price of $3.98.

agilon health Trading Up 15.5 %

The company has a market capitalization of $1.04 billion, a P/E ratio of -2.69 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock’s 50 day moving average is $2.07 and its 200-day moving average is $3.79.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the prior year, the business posted ($0.06) EPS. As a group, equities research analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current year.

Insider Transactions at agilon health

In related news, Director Karen Mcloughlin bought 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Diana Mckenzie bought 12,500 shares of the stock in a transaction on Monday, November 25th. The stock was purchased at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 90,000 shares of company stock valued at $198,100 in the last quarter. 3.20% of the stock is owned by insiders.

Hedge Funds Weigh In On agilon health

Several large investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its stake in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC boosted its stake in shares of agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the period. Citigroup Inc. grew its position in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in agilon health during the 2nd quarter valued at approximately $1,849,000. Finally, Geode Capital Management LLC lifted its holdings in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after purchasing an additional 84,889 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.